The Oxford University COVID-19 vaccine undergoing Phase III clinical trials with British pharma giant AstraZeneca is doing 'everything expected' which means good news in the fight against the......
United Kingdom-headquartered pharmaceutical giant AstraZeneca (AZ) has admitted that in 'very rare cases' its Covid vaccine can cause a blood clot related side effect but the causal link is......
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its COVID vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the......
A team of scientists from the world's leading universities has developed a new all-in-one vaccine that they hope can protect humans against a broad range of coronaviruses, including ones that are......
The coronavirus vaccine developed by Oxford University and AstraZeneca “should be” effective against the highly transmissible new strain of the virus, a United Kingdom media report said......
Serum Institute of India chief Adar Poonawalla will pay £138 million (about Rs 1,444 crore) for a Mayfair mansion in London in one of the city’s most expensive home sales of the year,......
'The challenge will be making sure its efficacy is high.''If a vaccine is only 50 to 60 per cent efficient, it's a double-edged sword.' Adar Poonawalla, chief executive officer, Serum Institute of......
Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine.Sohini Das profiles its 39-year-old CEO. IMAGE: Adar Poonawalla, right, and his father Dr Cyrus S......
The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......
The procurement and distribution will be centralised though the government is yet to take a call on the initial number of doses that will be procured. India plans to create a digital......